Moneycontrol
HomeNewsBusinessMarketsQ4 nos may not be good; pharma stocks costly now: Expert

Q4 nos may not be good; pharma stocks costly now: Expert

In an interview to CNBC-TV18, Independent market expert Ratnesh Kumar said most pharmaceutical companies are quite expensive now and therefore, it would be tough to increase allocation there.

April 12, 2015 / 17:17 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Independent market expert Ratnesh Kumar believes it is a long-term bull market now and so, in between there will be ups and downs. According to him, the basic challenge now is the earnings growth and March quarter is unlikely to end with very exciting numbers.

In an interview to CNBC-TV18, Kumar said most pharmaceutical companies are quite expensive now and therefore, it would be tough to increase allocation there.

Story continues below Advertisement

Below is verbatim transcript of the interview:

Q: Do you think market is back on the path of taking all time out and has the bull market resumed or do you think some more correction is left in the market?